Integrated Service Program was QHSLab’s largest product and service line in fiscal 2025, bringing in $1.12M of $2.69M (42%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Allergy Diagnostic Kit Sales | $666.60K | $832.99K | $823.11K |
| Integrated Service Program | $270.02K | $643.21K | $1.12M |
| Immunotherapy Treatment Sales | $363.18K | $409.32K | $487.76K |
| Clinical Study Revenue | — | $133.65K | $133.65K |
| Subscription Revenue | $72.20K | $54.52K | $43.73K |
| Shipping & Handling | $32.34K | $35.89K | $41.67K |
| Training & Other Revenue | $4.65K | $22.34K | $40.69K |
| Total | $1.41M | $2.13M | $2.69M |
QHSLab brought in $2.69M from its seven product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 26.3% from $2.13M in fiscal 2024. Integrated Service Program was the largest at $1.12M (41.7%), ahead of Allergy Diagnostic Kit Sales at $823.11K (30.6%) and Immunotherapy Treatment Sales at $487.76K (18.1%). The other four lines brought in $259.74K combined.
Compared with fiscal 2024, Integrated Service Program grew fastest, up 74.3% to $1.12M, while Allergy Diagnostic Kit Sales fell the most, down 1.2% to $823.11K.
QHSLab began breaking out Clinical Study Revenue in fiscal 2024, when it brought in $133.65K.
QHSLab (USAQ) reports its revenue by product and service. In fiscal 2025, Integrated Service Program was its largest product and service line, bringing in $1.12M (41.7% of the total), followed by Allergy Diagnostic Kit Sales at $823.11K (30.6%).
Integrated Service Program was QHSLab's largest product and service line in fiscal 2025, bringing in $1.12M, or 41.7% of the $2.69M total across its seven product and service lines.
Among QHSLab's product and service lines that make up at least 2% of revenue, Integrated Service Program grew fastest in fiscal 2025, up 74.3% from $643.21K to $1.12M.
Every figure comes from QHSLab's annual financial filings, as reported. Each line keeps the name QHSLab gives it, and years follow its fiscal calendar.
QHSLab's revenue by product and service goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.